Login / Signup

BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours.

Pashtoon Murtaza KasiSakti ChakrabartiSarah SawyerMichael KrainockAndrew PoklepovicGeorge AnsstasMinu ManinderMeenakshi MalhotraJoe EnsorLing GaoZeynep ErogluSascha EllersPaul BillingsAngel RodriguezAlexey Aleshin
Published in: BMJ open (2022)
NCT04761783.
Keyphrases
  • randomized controlled trial
  • study protocol
  • clinical trial
  • circulating tumor
  • double blind